NCT02707224View on ClinicalTrials.gov

Clinical Trial to Compare the Pharmacokinetics of DP-R208

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Healthy
Interventions
DRUG

DP-R208

Investigational product is prescribed to all of randomized subjects

DRUG

Candesartan cilexetil

Investigational product is prescribed to all of randomized subjects

DRUG

Rosuvastatin

Investigational product is prescribed to all of randomized subjects

Sponsors

Lead Sponsor

Alvogen Korea
All Listed Sponsors
lead

Alvogen Korea

INDUSTRY